Sterigenics International and Noxilizer announce partnership to provide NO2 sterilization for pharmaceutical, biotech and medical device products

Food and Healthcare Press Releases Wednesday October 4, 2017 07:49
BALTIMORE and BROADVIEW HEIGHTS, Ohio--4 Oct--PRNewswire/InfoQuest
  • Agreement supports customers with global manufacturing networks

Noxilizer, Inc. and   Sterigenics International LLC announce the signing of a global agreement that will make Sterigenics the exclusive worldwide provider of nitrogen dioxide (NO2) contract sterilization services, as well as feasibility and research studies, to the pharmaceutical, biotech and medical device manufacturing industries.

NO2-based sterilization was first commercialized by Noxilizer in 2012. Customers prefer nitrogen dioxide sterilization for its key advantages: ultra-low temperature (10-30 degrees Celsius), minimal pressure requirements, no cytotoxic residuals, and fast cycle times (2-4 hours, including aeration). NO2 sterilization opens new avenues for medical device innovation and has been shown to be particularly effective in the sterilization of prefilled syringes, drug-device combination products, and custom implants.

"We are very excited about our partnership with Sterigenics, as together we can rapidly expand NO2 sterilization capability for our customers," states Lawrence Bruder, President & CEO of Noxilizer. "Noxilizer's customers will now have large-scale facilities to meet their needs for contract services, redundancy and increasing volumes."

"Sterigenics is committed to providing our customers with efficient, state-of-the-art sterilization services using the processes best suited to their specific products," says Philip Macnabb, President of Sterigenics. "We regularly monitor new technologies and are excited to be able to add NO2 processing to our suite of offerings."

Noxilizer expects to have the first NO2 sterilization systems in place and operational in select Sterigenics' facilities in the United States and Europe by the end of the year with additional installations to follow. As part of the agreement, Sterigenics will also offer nitrogen dioxide sterilization consulting services to its customers.

Customers will also be able to benefit from the integrated testing services available through Sterigenics International's   Nelson Laboratories business.   "This unique combination of cutting edge sterilization technologies, expert consulting support, and full-service testing services will provide customers with unrivaled support in getting products to market quickly and reliably," says Jeff Nelson, President of Nelson Labs.

"Sterigenics has set a high standard for matching the needs of its customers with the best available sterilization technologies," Lawrence Bruder concluded. "Noxilizer shares this commitment to excellence and we look forward to working with the Sterigenics International team as they continue to reshape the market."

About Sterigenics International LLC:

Sterigenics International LLC, along with its affiliates, is a global leader in outsourced contract sterilization services, laboratory services, gamma technologies and medical isotopes, and the only vertically integrated sterilization company in the world. Operating out of 51 locations in 13 countries across the Americas, Europe and Asia, Sterigenics provides contract sterilization and ionization services for the medical device, pharmaceutical, food safety, and high-performance materials industries. Its affiliate Nordion positions Sterigenics as the world's largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Through Nelson Labs, Sterigenics offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and pharmaceuticals and biologics fields. Sterigenics International LLC and its affiliates serve more than 2,500 customers around the world and is owned by private equity firms Warburg Pincus and GTCR. Learn more about Sterigenics at sterigenics.com , about Nordion at   nordion.com and about Nelson Labs at nelsonlabs.com .

About Noxilizer, Inc.:

Noxilizer, Inc. provides an ultra-low temperature nitrogen dioxide process that offers many benefits over traditional sterilization and biodecontamination methods. Noxilizer sells sterilization and biodecontamination equipment to pharmaceutical, biotech and medical device manufacturers. Noxilizer's expert microbiology and material compatibility team is ready to partner to solve sterilization challenges through every phase of the process. Noxilizer, Inc. has offices in the United States and Japan. For more information, please visit: www.noxilizer.com .

Sterigenics International LLC Media Contact:
Dan Pfeffer
Public Affairs Advisors
514-919-9822
dan.pfeffer@publicaffairsadvisors.com
NOXILIZER Press Contact:
Maura O. Kahn
Vice President, Business Development & Marketing
O (443) 842-4403
C (202) 744-6337
mokahn@noxilizer.com

Latest Press Release

Merck Brings Customers Closer to Gene Therapy Product Commercialization

- Highlights position as leading contract manufacturing organization (CMO) for production of next-generation gene therapies Merck , a leading science and technology company, today announced that its Carlsbad, California-based manufacturing facility for...

Anpac Bio Surpasses 50,000 Case Study Milestone #Liquid Biopsy Pioneer# Serving Individual, Medical, Insurance Corporate Customers

Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company , announced this week the company set a new, international record, processing and reporting over 50,000 cases worldwide of the company's...

Photo Release: The Royal Danish Embassy and Novo Nordisk join together to support the World Diabetes Day 2017 event, held on November 5, 2017

Recently, Mr.Uffe Wolffhechel, Ambassador of the Royal Danish Embassy, Thailand (right) together with Mr.Mihai Irimescu, General Manager of Novo Nordisk Pharma (Thailand) Co., Ltd (left) gave a special press interview on the 2017 World Diabetes Day event...

Pulsus Healthtech meetings and digital media coalition helping physicians# continued medical education

Pulsus Group is committed to working with medical societies and policymakers to improve the global healthcare education through its global medical and scientific conferences. With a legacy of 30 years of excellence in medical publishing and support from...

Avnet and MedIoTek to Transform Healthcare Delivery in India

Avnet (NYSE: AVT ), a leading global technology distributor, and MedIoTek Health Systems, announce a joint marketing agreement to promote MedIoTek's VinCense remote patient monitoring system. Under the agreement, Avnet will engage its broad network of...

Related Topics